Medical Store Opening Made Easy In UP

Lucknow:  While granting a license to open a pharmaceutical company and sell medicines, entrepreneurs will no longer be subjected to rules like size of the firm, investment, domestic or foreign investor and business risk like other businesses.

Due to its inclusion in Invest UP’s Business Reform Action Plan (BRAP)-2024, entrepreneurs are facing difficulties in getting licenses. In such a situation, the Food Safety and Drug Administration Department has written a letter demanding exemption from this.

While granting license for setting up a pharmaceutical company or for sale of medicines under the Drug and Cosmetic Act, only the storage capacity as per standards, facility to keep medicines at low temperature and registration of pharmacist are considered.

According to BRAP-2024 of Invest UP, the Food Safety and Drug Administration Department has already made arrangements for granting and monitoring licenses through an online portal. There is also a system to deposit fees online for the license and to see with which officer the file is pending or everything online.

In such a situation, Principal Secretary, Food Safety and Drug Administration P. Guruprasad sent a letter to the Chief Executive Officer of Invest UP demanding exemption from rules like size of firm etc. under BRAP, because there is no provision for this in the Drug and Cosmetic Act, hence it cannot be implemented. At present, after getting the exemption, the drug entrepreneurs will get a lot of relief.

Related Posts

  • Pharma
  • February 5, 2025
  • 119 views
Pharma stock jumps after it launches Kojiglo serum in India for facial hyperpigmentation

A leading pharmaceutical powerhouse renowned for innovative skincare solutions has unveiled its latest breakthrough in tackling facial hyperpigmentation. The groundbreaking serum, featuring a first-of-its-kind dual liposomal technology in India, promises…

  • Pharma
  • February 5, 2025
  • 127 views
Uniform Code Of Pharmaceuticals Marketing Practices 2024 Outlines Guidelines Regarding Promotion Of Drugs Among Doctors: Minister

New Delhi: With the aim of preventing unethical marketing and ensuring responsible promotion of pharmaceutical products by regulating interactions between doctors / registered medical practitioners (RMPs) and representatives of pharmaceutical…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

As Always Ahead of Game in healthcare, Doc was first to vote too

As Always Ahead of Game in healthcare, Doc was first to vote too

Pharma stock jumps after it launches Kojiglo serum in India for facial hyperpigmentation

Pharma stock jumps after it launches Kojiglo serum in India for facial hyperpigmentation

Uniform Code Of Pharmaceuticals Marketing Practices 2024 Outlines Guidelines Regarding Promotion Of Drugs Among Doctors: Minister

Uniform Code Of Pharmaceuticals Marketing Practices 2024 Outlines Guidelines Regarding Promotion Of Drugs Among Doctors: Minister

Dabur reduces strategic review cycle to 3 years amidst short-term volatility, FMCG slowdown

Dabur reduces strategic review cycle to 3 years amidst short-term volatility, FMCG slowdown

Sun Pharma appoints Aalok Shanghvi as Chief Operating Officer

Sun Pharma appoints Aalok Shanghvi as Chief Operating Officer

Alembic Pharma Q3 results: PAT falls 23.29% amid market headwinds

Alembic Pharma Q3 results: PAT falls 23.29% amid market headwinds